NANO MRNA Revenue

In the fiscal year ending March 31, 2025, NANO MRNA had annual revenue of 108.00M JPY, down -20.00%. NANO MRNA had revenue of 25.00M in the quarter ending March 31, 2025, a decrease of -19.35%.

Revenue

108.00M

Revenue Growth

-20.00%

P/S Ratio

90.20

Revenue / Employee

5.40M

Employees

Market Cap

9.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	108.00M	-27.00M	-20.00%
Mar 31, 2024	135.00M	-67.00M	-33.17%
Mar 31, 2023	202.00M	84.18M	71.45%
Mar 31, 2010	117.82M	-235.83M	-66.68%
Mar 31, 2009	353.65M	90.93M	34.61%
Mar 31, 2008	Pro	Pro	Pro
Mar 31, 2007	Pro	Pro	Pro
Mar 31, 2006	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Takeda Pharmaceutical Company	4,581.55B
Daiichi Sankyo Company	1,886.26B
HOYA Corporation	866.03B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Shionogi &	438.27B

Revenue Rankings